Piperazine → HCID 13371669, compound
Reaction equation
Cl[C:2]1[N:11]=[C:10]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][CH2:13]2)[C:9]2[C:4](=[N:5][C:6]([N:19]3[CH2:24][CH2:23][S:22](=[O:25])[CH2:21][CH2:20]3)=[C:7]([Cl:18])[N:8]=2)[N:3]=1.[NH:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1>>[Cl:18][C:7]1[N:8]=[C:9]2[C:4](=[N:5][C:6]=1[N:19]1[CH2:24][CH2:23][S:22](=[O:25])[CH2:21][CH2:20]1)[N:3]=[C:2]([N:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1)[N:11]=[C:10]2[N:12]1[CH2:17][CH2:16][O:15][CH2:14][CH2:13]1Participants
3
Procedure
This compound was prepared analogous to Example 1 from 2,6-dichloro-4-morpholino-7-(1-oxido-thiomorpholino)pteridine and piperazine.
Sources & evidence
- ORD record
- ord-bdaf5f4aad2f49a1bb909275fc4f8091
- Source dataset
- uspto-grants-1985_12
- Patent number
- US04560685
Reaction notes
Loading…